Abiopharma

Annual Reports and Related Documents:

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of interest/ Changes in interest of Directors/ Chief Executive Officer

General Announcement: Sale of Treasury Shares

Change - Announcement of Appointment: Announcement of Appointment of Independent Non-Executive Director

(30% Negative) KYMERA THERAPEUTICS, INC. (KYMR) Reports Q2 2026 Financial Results

Sima Ruobai 🟡 adjusted position in 4.2M shares (1 derivative) of ATA Creativity Global (AACG) at $0.79 Transaction Date: Apr 30, 2026 | Filing ID: 052116

General Announcement: Net Tangible Assets ("NTA") Per Share

Change - Announcement of Cessation: Retirement of Independent Non-Executive Director

(25% Negative) VISTANCE NETWORKS, INC. (VISN) Reports Q2 2026 Financial Results

(90% Positive) UNIQURE N.V. (QURE) Provides Update on granted for AMT-130 in Huntington’s disease